在患有冠状病毒感染的儿童中评估治疗有效性
Olesya M Horlenko1, Khrystyna A Hechko1, Lyubomyra B Prylypko1
1UZHHOROD NATIONAL UNIVERSITY, UZHHOROD, UKRAINE.
Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego
|December 17, 2024
概括
治疗冠状病毒感染儿童的治疗显示出积极的结果,使维生素D3和水平正常化. 治疗后炎症标志物显著下降,表明健康结果有所改善.
科学领域:
- 儿童传染病 儿童传染病
- 免疫学 免疫学 免疫学
- 生物化学 生化学
背景情况:
- 冠状病毒感染对儿童造成重大健康风险,影响各种生理标志物.
- 了解治疗有效性对于管理儿科COVID-19病例至关重要.
研究的目的:
- 评估诊断为冠状病毒感染的儿童治疗方案的有效性.
- 分析治疗后临床和生化参数的变化.
主要方法:
- 一项涉及68名确诊冠状病毒感染的儿童的研究,与28名的对照组相比.
- 在治疗前和治疗后分析完整血清 (CBC),维生素D3,,免疫球蛋白水平和炎症标志物.
主要成果:
- 治疗导致大多数CBC参数的积极动态,除了血小板和乙蛋白.
- 维生素D3和水平正常化,而免疫球蛋白水平初步上升,随后正常化.
- 在治疗后观察到IL-1,IL-6,TNF-α,CRP和D-二次体等炎症标志物的显著减少.
结论:
- 研究中的治疗方法有效地改善了冠状病毒感染儿童的临床和生化参数.
- 治疗有助于使关键指标正常化,减少炎症,有助于恢复.
- 进一步的监测表明,在六个月内,某些代谢标志物的持续积极趋势和正常化.
关键词:
复发性呼吸道疾病的复发性疾病.冠状病毒病毒疾病 冠状病毒疾病孩子们的孩子们的孩子们的孩子们.临床和实验室动态检查的临床和实验室动态检查≪后COVID-19综合征≫是指发生后COVID-19综合征的情况.更多相关视频
相关概念视频
Pneumonia IV: Management
298
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
298
Antimicrobial Effectiveness
The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
Acute Respiratory Failure-V
123
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Ensure that patients are monitored continuously for their response to therapy, including changes in...
123


